Navigation Links
U.S. Officials Take Aim at Questionable STD Products

TUESDAY, May 3 (HealthDay News) -- The U.S. Food and Drug Administration and the U.S. Federal Trade Commission are cracking down on manufacturers of over-the-counter products that claim to treat, cure or prevent sexually transmitted diseases.

The agencies jointly sent letters to companies including Medavir, Herpaflor, Viruxo, C-Cure and Never An Outbreak, warning that their products are unproven and violate federal law, the FDA said in a news release issued Tuesday.

"These products are dangerous because they are targeted to patients with serious conditions, where treatment options proven to be safe and effective are available," Deborah M. Autor, director of the Office of Compliance in the FDA's Center for Drug Evaluation and Research, said in the release.

Chlamydia, genital warts, herpes, HIV and AIDS are among the diseases that the products -- sold online and through retail outlets -- claim to treat. However, the only FDA-approved medications available to treat these conditions require a prescription and supervision of a health-care professional, the agency said.

Because the products have not been evaluated for safety and effectiveness, people who buy them may not get needed treatment and could then infect their sexual partners, Autor said.

The items are considered drug products under the Federal Food, Drug, and Cosmetic Act because they are sold to treat disease, and they violate interstate commerce law if they lack an FDA-approved new drug application, the FDA explained. Further, under the Federal Trade Commission Act it is illegal to make unsubstantiated treatment claims, regulators said.

"These companies are on notice that advertising health benefits that are not supported by rigorous scientific evidence violates the FTC Act," said David Vladeck, director of the FTC's Bureau of Consumer Protection. Health scams that endanger public health will not be tolerated, he added.

The letters are the first step in removing the unproven products from the market. The companies have 15 days to inform the FDA of measures they're taking to correct the alleged violations or face possible legal action.

More information

The U.S. National Library of Medicine has more about sexually transmitted diseases.

-- HealthDay staff

SOURCE: U.S. Food and Drug Administration, news release, May 3, 2011

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Online Tool Created to Contact Vatican Officials: Why Are American Bishops Allowed to Defy the Popes Words Concerning Child Killing and the Eucharist?
2. Officials See Uptick in H1N1 Swine Flu Cases
3. Infant Sleep Positioners Dangerous, U.S. Health Officials Warn
4. U.S. Officials Recommend Reduced Fluoride Levels in Water
5. LearnSomething Brings Phil Keough On Board to Spearhead Retail Products and Services
6. Health & Sports: Former NBA Star John Salley Endorses STEMTech Stem Cell Nutrition Products
7. For a Healthier, Cleaner Fitness Regimen - Venture Products Shock Athletic(TM) Mats and Interlocking Flooring
8. Human Dental Technology Leads to Breakthroughs for Pet Dental Health at Sergeants Pet Care Products, Inc.
9. Summit VetPharm Enters Agreement With MWI Veterinary Supply to Distribute Vectra(R) Products
10. GNC Announces Entry to Chinas Nutritional Products in Partnership with Bright Food
11. First Coast Service Options (FCSO) Expands Use of Burgess Products
Post Your Comments:
Related Image:
U.S. Officials Take Aim at Questionable STD Products 
(Date:10/12/2017)... WAUSAU, Wis. (PRWEB) , ... October 12, 2017 ... ... formulated standard products to meet the demand of today’s consumer and regulatory authorities ... team of probiotic experts and tested to meet the highest standard. , ...
(Date:10/12/2017)... ... ... The American College of Medical Informatics (ACMI) will present the 2017 Morris F. ... AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is taking place ... the field of medical informatics, this prestigious award is presented to an individual whose ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in healthcare ... Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during ... , The annual award competition recognizes editorial and design excellence across a range of ...
(Date:10/12/2017)... ... 12, 2017 , ... On Saturday, October 21, the Health & Wellness Center ... to raise money for the American Heart Association Heart Walk. Teams of up to ... together to keep their treadmills moving for 5 hours. Treadmills will start at 7:00 ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
(Date:9/19/2017)... medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed sound energy ... ... Jim Bertolina, PhD ... Tom Tefft ... executive Josh Stopek , PhD, who has led R&D and business development teams at ...
(Date:9/18/2017)... Sept. 18, 2017 EpiVax, Inc. ... bioinformatics and immune engineering, today announced a ... A (H7N9) vaccine. ... seasonal influenza and presents a challenge for ... exposure to be effective. Using state-of-the-art bioinformatics and ...
Breaking Medicine Technology: